UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 98

Sortiert nach

Circulating Tumor Cells, Disease Progression, and Survival in Metastatic Breast Cancer

The New England journal of medicine, 2004-08, Vol.351 (8), p.781-791

2004

Link zum Volltext

Verfügbarkeit prüfen

Randomized Phase III Study of Docetaxel Compared With Paclitaxel in Metastatic Breast Cancer

Journal of clinical oncology, 2005-08, Vol.23 (24), p.5542-5551

2005

Link zum Volltext

Verfügbarkeit prüfen

Circulating Tumor Cells: A Novel Prognostic Factor for Newly Diagnosed Metastatic Breast Cancer

Journal of clinical oncology, 2005-03, Vol.23 (7), p.1420-1430

2005

Link zum Volltext

Verfügbarkeit prüfen

Abstract P5-14-07: Impact of time to treatment (TTT) on recurrence free survival in non metastatic invasive breast cancer

Cancer research (Chicago, Ill.), 2017-02, Vol.77 (4_Supplement), p.P5-P5-14-07

2017

Link zum Volltext

Verfügbarkeit prüfen

Abstract P1-10-01: Defining the spectrum of germline variants among African American patients with triple negative breast cancer

Cancer research (Chicago, Ill.), 2019-02, Vol.79 (4_Supplement), p.P1-P1-10-01

2019

Link zum Volltext

Verfügbarkeit prüfen

Abstract OT2-01-10: Pilot study of carboplatin, nab-paclitaxel and pembrolizumab for metastatic triple-negative breast cancer (ongoing clinical trial)

Cancer research (Chicago, Ill.), 2017-02, Vol.77 (4_Supplement), p.OT2-01-10-OT2-01-10

2017

Link zum Volltext

Verfügbarkeit prüfen

Abstract P2-12-04: Impact of institution of young women's breast cancer clinic on time to treatment and utilization of fertility, genetics and social work consultations in women under age 50 with new diagnosis of early stage breast cancer

Cancer research (Chicago, Ill.), 2017-02, Vol.77 (4_Supplement), p.P2-P2-12-04

2017

Link zum Volltext

Verfügbarkeit prüfen

Abstract P5-21-26: T-DM1 activity in metastatic HER2-positive breast cancer patients who have received prior trastuzumab and pertuzumab: NSABP B-005

Cancer research (Chicago, Ill.), 2018-02, Vol.78 (4_Supplement), p.P5-P5-21-26

2018

Link zum Volltext

Verfügbarkeit prüfen

Abstract P1-09-03: Socioeconomic characteristics of African American women with breast cancer

Cancer research (Chicago, Ill.), 2016-02, Vol.76 (4_Supplement), p.P1-P1-09-03

2016

Link zum Volltext

Verfügbarkeit prüfen

Abstract OT1-01-02: Pilot trial of a type I polarized autologous dendritic cell vaccine incorporating tumor blood vessel antigen-derived peptides in patients with metastatic breast cancer

Cancer research (Chicago, Ill.), 2016-02, Vol.76 (4_Supplement), p.OT1-01-02-OT1-01-02

2016

Link zum Volltext

Verfügbarkeit prüfen

Abstract P4-13-24: Impact of genomic medicine on clinical decision making in patients with advanced breast cancer at two academic medical centers

Cancer research (Chicago, Ill.), 2016-02, Vol.76 (4_Supplement), p.P4-P4-13-24

2016

Link zum Volltext

Verfügbarkeit prüfen

Abstract P4-11-04: Targeted vaccination against human a-lactalbumin may provide immunotherapy and immunoprevention of triple negative breast cancer

Cancer research (Chicago, Ill.), 2013-12, Vol.73 (24_Supplement), p.P4-P4-11-04

2013

Link zum Volltext

Verfügbarkeit prüfen

Phase 1 trial of Anvirzel in patients with refractory solid tumors

Investigational new drugs, 2006-09, Vol.24 (5), p.423-427

2006

Link zum Volltext

Verfügbarkeit prüfen

Abstract P5-18-06: Trastuzumab emtansine in HER2-positive metastatic breast cancer: pooled safety analysis from seven studies

Cancer research (Chicago, Ill.), 2012-12, Vol.72 (24_Supplement), p.P5-P5-18-06

2012

Link zum Volltext

Verfügbarkeit prüfen

P1-07-05: HER2 Status Resolution in FISH and IHC “Double Equivocal” Breast Carcinomas by Quantitative Real-Time PCR

Cancer research (Chicago, Ill.), 2011-12, Vol.71 (24_Supplement), p.P1-P1-07-05

2011

Link zum Volltext

Verfügbarkeit prüfen

Abstract PD02-04: Automated Quantitative RNA In Situ Hybridization for Resolution of Equivocal and Heterogeneous ERBB2 (HER2) Status in Invasive Breast Carcinoma

Cancer research (Chicago, Ill.), 2012-12, Vol.72 (24_Supplement), p.PD02-04-PD02-04

2012

Link zum Volltext

Verfügbarkeit prüfen

The incidence of topoisomerase II-alpha genomic alterations in adenocarcinoma of the breast and their relationship to human epidermal growth factor receptor-2 gene amplification: A fluorescence in situ hybridization study

Human pathology, 2005-04, Vol.36 (4), p.348-356

2005

Link zum Volltext

Verfügbarkeit prüfen

Abstract P2-13-02: Effect of aspirin (ASP) or celecoxib (CC) use on outcomes in postmenopausal breast cancer patients randomized to adjuvant exemestane or anastrozole: NCIC CTG MA.27

Cancer research (Chicago, Ill.), 2012-12, Vol.72 (24_Supplement), p.P2-P2-13-02

2012

Link zum Volltext

Verfügbarkeit prüfen

Delivering adjuvant chemotherapy to women with early-stage breast carcinoma : Current patterns of care

Cancer, 2001-09, Vol.92 (6), p.1354-1367

2001

Link zum Volltext

Verfügbarkeit prüfen

Multicenter randomized clinical trial of goserelin versus surgical ovariectomy in premenopausal patients with receptor-positive metastatic breast cancer: an intergroup study

Journal of clinical oncology, 1998-03, Vol.16 (3), p.994-999

1998

Link zum Volltext

Verfügbarkeit prüfen

Adjuvant therapy of osteosarcoma: A phase II trial: Southwest oncology group study 9139

Cancer, 2004-02, Vol.100 (4), p.818-825

2004

Link zum Volltext

Verfügbarkeit prüfen

Abstract S1-1: Final Analysis of NCIC CTG MA.27: A Randomized Phase III Trial of Exemestane Versus Anastrozole in Postmenopausal Women with Hormone Receptor Positive Primary Breast Cancer

Cancer research (Chicago, Ill.), 2010-12, Vol.70 (24_Supplement), p.S1-S1-1

2010

Link zum Volltext

Verfügbarkeit prüfen

Phase I Trial of Exisulind (Sulindac Sulfone, FGN-1) as a Chemopreventive Agent in Patients with Familial Adenomatous Polyposis

Clinical cancer research, 2000-01, Vol.6 (1), p.78-89

2000

Link zum Volltext

Verfügbarkeit prüfen

Calpain regulates sensitivity to trastuzumab and survival in HER2-positive breast cancer

Cancer research (Chicago, Ill.), 2009-01, Vol.69 (2_Supplement), p.2018

2009

Link zum Volltext

Verfügbarkeit prüfen

HER2 amplification predicts breast cancer recurrence but not overall survival

Cancer research (Chicago, Ill.), 2009-01, Vol.69 (2_Supplement), p.6070

2009

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 98

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(95)
Mit Volltextzugriff
(84)

Publikationsform

Artikel
(97)
Buchkapitel
(1)

Sprache

Englisch
(98)
Japanisch
(7)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(79)
Science & Technology
(79)
Humans
(77)
Oncology
(69)
Female
(58)
Biological And Medical Sciences
(57)
Medical Sciences
(56)
Middle Aged
(54)
Adult
(51)
Aged
(44)
Pharmacology. Drug Treatments
(42)
Antineoplastic Agents
(38)
Male
(37)
Chemotherapy
(23)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(21)
Neoplasms - Drug Therapy
(16)
Pharmacology & Pharmacy
(16)
Tumors
(16)
Immunotherapy
(15)
Neoplasm Metastasis
(15)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Circulating Tumor Cells, Disease Progression, and Survival in Metastatic Breast Cancer

Randomized Phase III Study of Docetaxel Compared With Paclitaxel in Metastatic Breast Cancer

Circulating Tumor Cells: A Novel Prognostic Factor for Newly Diagnosed Metastatic Breast Cancer

Abstract P5-14-07: Impact of time to treatment (TTT) on recurrence free survival in non metastatic invasive breast cancer

Abstract P1-10-01: Defining the spectrum of germline variants among African American patients with triple negative breast cancer

Abstract OT2-01-10: Pilot study of carboplatin, nab-paclitaxel and pembrolizumab for metastatic triple-negative breast cancer (ongoing clinical trial)

Abstract P2-12-04: Impact of institution of young women's breast cancer clinic on time to treatment and utilization of fertility, genetics and social work consultations in women under age 50 with new diagnosis of early stage breast cancer

Abstract P5-21-26: T-DM1 activity in metastatic HER2-positive breast cancer patients who have received prior trastuzumab and pertuzumab: NSABP B-005

Abstract P1-09-03: Socioeconomic characteristics of African American women with breast cancer

Abstract OT1-01-02: Pilot trial of a type I polarized autologous dendritic cell vaccine incorporating tumor blood vessel antigen-derived peptides in patients with metastatic breast cancer

Abstract P4-13-24: Impact of genomic medicine on clinical decision making in patients with advanced breast cancer at two academic medical centers

Abstract P4-11-04: Targeted vaccination against human a-lactalbumin may provide immunotherapy and immunoprevention of triple negative breast cancer

Phase 1 trial of Anvirzel in patients with refractory solid tumors

Abstract P5-18-06: Trastuzumab emtansine in HER2-positive metastatic breast cancer: pooled safety analysis from seven studies

P1-07-05: HER2 Status Resolution in FISH and IHC “Double Equivocal” Breast Carcinomas by Quantitative Real-Time PCR

Abstract PD02-04: Automated Quantitative RNA In Situ Hybridization for Resolution of Equivocal and Heterogeneous ERBB2 (HER2) Status in Invasive Breast Carcinoma

The incidence of topoisomerase II-alpha genomic alterations in adenocarcinoma of the breast and their relationship to human epidermal growth factor receptor-2 gene amplification: A fluorescence in situ hybridization study

Abstract P2-13-02: Effect of aspirin (ASP) or celecoxib (CC) use on outcomes in postmenopausal breast cancer patients randomized to adjuvant exemestane or anastrozole: NCIC CTG MA.27

Delivering adjuvant chemotherapy to women with early-stage breast carcinoma : Current patterns of care

Multicenter randomized clinical trial of goserelin versus surgical ovariectomy in premenopausal patients with receptor-positive metastatic breast cancer: an intergroup study

Adjuvant therapy of osteosarcoma: A phase II trial: Southwest oncology group study 9139

Abstract S1-1: Final Analysis of NCIC CTG MA.27: A Randomized Phase III Trial of Exemestane Versus Anastrozole in Postmenopausal Women with Hormone Receptor Positive Primary Breast Cancer

Phase I Trial of Exisulind (Sulindac Sulfone, FGN-1) as a Chemopreventive Agent in Patients with Familial Adenomatous Polyposis

Calpain regulates sensitivity to trastuzumab and survival in HER2-positive breast cancer

HER2 amplification predicts breast cancer recurrence but not overall survival

Suchergebnisse filtern